Freedman Financial Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,185
| Closed | -$519K | – | 319 |
|
|
2022
Q1 | $519K | Buy |
10,185
+638
| +7% | +$32.5K | 0.36% | 36 |
|
|
2021
Q4 | $564K | Sell |
9,547
-53
| -0.6% | -$3.13K | 0.39% | 33 |
|
|
2021
Q3 | $413K | Buy |
9,600
+106
| +1% | +$4.56K | 0.3% | 38 |
|
|
2021
Q2 | $372K | Sell |
9,494
-1,700
| -15% | -$66.6K | 0.28% | 40 |
|
|
2021
Q1 | $406K | Sell |
11,194
-300
| -3% | -$10.9K | 0.34% | 36 |
|
|
2020
Q4 | $423K | Buy |
+11,494
| New | +$423K | 0.38% | 32 |
|